Hi Babba
There is a difference between the FDA and EMA (TGA is harmonized most closely to the EMA) in terms of approval process. They do however share information when appropriate and there is increasing harmonization where it is structurally similar.
https://pharmanewsintel.com/features/regulating-and-authorizing-medicines-a-comparison-of-the-fda-and-ema
https://www.sciencedirect.com/science/article/pii/S2452302X16300638
Some device and drug companies will have a split strategy and apply in the EU or Aus and then use data from approved products to apply to the FDA.
PAR has gone for a multicentre approach and is Targeting USA as a key first market. This does risk any failure being in multiple jurisdictions. It is also more cash draining.
- Forums
- ASX - By Stock
- PAR
- Where we at?
Where we at?, page-552
-
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.95M |
Open | High | Low | Value | Volume |
24.5¢ | 24.5¢ | 23.3¢ | $74.59K | 314.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 28833 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 21738 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 23833 | 0.235 |
8 | 184540 | 0.230 |
10 | 216973 | 0.225 |
14 | 170113 | 0.220 |
5 | 77958 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 21738 | 1 |
0.245 | 40000 | 1 |
0.250 | 30000 | 1 |
0.255 | 76689 | 6 |
0.260 | 6349 | 2 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |